Natco Pharma rolls out ‘most affordable’ semaglutide in India; check prices here
Natco Pharma also plans to launch a pen device version in April 2026, priced between ₹4,000 and ₹4,500 per month, depending on dosage.
admin
Oil disruption may ease slowly, but LNG supply hit could last years: Rystad Energy
Claudio Galimberti, Chief Economist & Global Director of Market Analysis at Rystad Energy says supply bottlenecks and slow production recovery could keep energy markets volatile in the months ahead.
Why gold discounts narrowed in India while China sees weaker premiums
Discounts on physical gold in India narrowed due to festival buying and global price corrections. Rajesh Rokde noted a 10% sales increase during Gudi Padwa.
Copper prices may have peaked sooner-than-expected
The fall in copper price was expected, not the timing and pace. Despite its vital role in the world’s digital transition, near-term prices may remain volatile.
What should investors now do with OMCs after a 25% fall in March? HDFC Securities answers
Varun Lohchab, Head of Institutional Research at HDFC Securities, says metals remain a tactical play with limited upside after the recent rally, as the firm shifts to equal weight. He sees selective value emerging in private banks post correction, while…
Dr Lal PathLabs in focus as Citi sees 25% upside; check target price here
Citi upgraded Dr Lal Pathlabs Ltd to ‘buy’ from ‘sell’, targeting ₹1,650 per share. The diagnostics sector has stabilized, with expected 10-12% organic revenue growth and strong EBITDA margins.
HDFC Bank shares enter ‘bear market’ zone after fourth straight weekly drop
Brokerage firm Jefferies maintained its “buy” rating on HDFC Bank with a price target of ₹1,240, which implies an upside potential of 59% from current levels. This is also the second-highest price target on the street for HDFC Bank, among…
Aurobindo Pharma arm receives VAI classification from USFDA for Telangana unit
Aurobindo Pharma’s subsidiary, Apitoria Pharma, received a ‘Voluntary Action Indicated’ (VAI) classification from the USFDA for its Telangana facility after a December 2025 inspection.
Coal India subsidiary CMPDI IPO opens amidst subdued GMP; Should you bid?
CMPDI offers services that range from coal and mineral exploration, mine planning & design services, environmental services, laboratory services, coal beneficiations services and mine closure activities as well.
Tata Steel shares can rise another 31%, HSBC says, as import protections in place
36 analysts have coverage on Tata Steel, 23 of them have a “buy” rating, seven say “hold”, while six have a “sell” rating on the stock. The consensus estimates project an upside potential of 7.6% from Thursday’s close.